People: HCP Inc (HCP)
HCP on New York Consolidated
44.16USD
19 Jun 2013
44.16USD
19 Jun 2013
Price Change (% chg)
$-1.82 (-3.96%)
$-1.82 (-3.96%)
Prev Close
$45.98
$45.98
Open
$45.85
$45.85
Day's High
$46.10
$46.10
Day's Low
$44.11
$44.11
Volume
2,806,637
2,806,637
Avg. Vol
2,762,006
2,762,006
52-wk High
$56.06
$56.06
52-wk Low
$42.00
$42.00
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
James Flaherty |
55 | 2006 | Chairman of the Board, Chief Executive Officer |
Kenneth Roath |
77 | 2005 | Independent Chairman Emeritus |
Timothy Schoen |
45 | 2011 | Chief Financial Officer, Executive Vice President |
Paul Gallagher |
52 | 2006 | Executive Vice President, Chief Investment Officer |
James Mercer |
68 | 2011 | Executive Vice President, General Counsel, Corporate Secretary |
Jonathan Bergschneider |
38 | 2011 | Executive Vice President - Life Science Estates |
Edward Henning |
60 | 2010 | Executive Vice President |
Thomas Kirby |
66 | 2009 | Executive Vice President - Acquisitions and Valuations |
Thomas Klaritch |
55 | 2008 | Executive Vice President - Medical Office Properties |
Susan Tate |
52 | 2012 | Executive Vice President - Post Acute and Hospitals |
Kendall Young |
52 | 2012 | Executive Vice President - Senior Housing |
Michael McKee |
67 | 2012 | Lead Independent Director |
Christine Garvey |
67 | 2007 | Independent Director |
David Henry |
64 | 2004 | Independent Director |
Lauralee Martin |
62 | 2008 | Independent Director |
Peter Rhein |
71 | 1985 | Independent Director |
Joseph Sullivan |
70 | 2004 | Independent Director |
Biographies
| Name | Description |
|---|---|
James Flaherty |
Mr. James F. Flaherty, III, is Chairman of the Board, Chief Executive Officer of HCP Inc. He has been Chairman of the company Board of Directors since May 2005, the company Chief Executive Officer since May 2003, and the company President and a member of the company Board since joining the company in October 2002. Prior to joining HCP, he served at Merrill Lynch & Co. for 19 years in a variety of investment banking, capital markets and private equity functions in New York, London and Los Angeles and was head of Merrill Lynch's Global Healthcare Group. Mr. Flaherty is a member of the Board of Trustees of the University of Notre Dame and the Board of Governors of the National Association of Real Estate Investment Trusts ("NAREIT"). He also previously served on the Board of Directors of Quest Diagnostics Incorporated. |
Kenneth Roath |
Mr. Kenneth B. Roath is Independent Chairman Emeritus of HCP, Inc., since May 16, 2005. He is Chairman of the company Board of Directors since 1988 and a member of the Board since 1986. Mr. Roath joined HCP at its inception in March 1985, and prior to it becoming a public company, served as President and Chief Operating Officer. From 1988 until May 2003, he was the company Chief Executive Officer. Mr. Roath has served on the boards of Arden Realty, Inc., Franchise Finance Corporation of America and Spirit Finance Corporation and is a former Chairman of NAREIT. |
Timothy Schoen |
Mr. Timothy M. Schoen has been appointed as Chief Financial Officer, Executive Vice President of HCP Inc., effective May 31, 2011. He was previously Executive Vice President—Life Science and Investment Management since January 2009 and prior to that time was Senior Vice President, Investment Management since January 2007 and Vice President - Acquisitions/Dispositions from April 2006 to January 2007. From 1997 until he joined HCP, Mr. Schoen was employed by Kilroy Realty Corporation (NYSE: KRC), a REIT that owns, develops and operates office and industrial buildings, and served as its Vice President, Corporate Finance. |
Paul Gallagher |
Mr. Paul F. Gallagher is Executive Vice President and Chief Investment Officer of HCP, Inc. He previsously served as Executive Vice President - Portfolio Strategy in October 2003. From 1988 until he joined HCP, Mr. Gallagher was employed by GE Capital Real Estate, including most recently as Managing Director of its Strategic Ventures department. |
James Mercer |
Mr. James W. Mercer is Executive Vice President, General Counsel, Corporate Secretary of HCP, Inc., since July 1, 2011. He was previously Of Counsel at Bryan Cave LLP for five years. Mr. Mercer has over 40 years of experience serving in both legal counsel and senior management capacities, including 15 years as a Partner at Hennigan, Mercer & Bennett and five years as Special Counsel at WebMD Corporation. |
Jonathan Bergschneider |
Mr. Jonathan M. Bergschneider is Executive Vice President - Life Science Estates of HCP Inc. He served as Senior Vice President—Life Science Estates from January 2008 to May 2011. Mr. Bergschneider joined HCP in 2007 as Vice President in conjunction with the Company's acquisition of Slough Estates (USA). He was previously employed by Slough Estates from 2000 to 2007 during the creation and build-out of that company's life science portfolio. |
Edward Henning |
Mr. Edward J. Henning is Executive Vice President of HCP Inc. He served as the company Executive Vice President, General Counsel and Corporate Secretary from January 2007 to May 2010, and as the company Chief Administrative Officer from January 2008 to May 2010. From 1995 until January 2007, Mr. Henning served as the company Senior Vice President, General Counsel and Corporate Secretary. He joined the company in 1994 as Vice President, Senior Legal Counsel and Corporate Secretary. Previously, Mr. Henning was Vice President and Legal Counsel at Weyerhaeuser Mortgage Company from 1992 to 1994. Prior to that, he was in private practice at Latham & Watkins. |
Thomas Kirby |
Mr. Thomas D. Kirby is Executive Vice President - Acquisitions and Valuations of HCP Inc., since January 2009. Mr. Kirby previously served as Senior Vice President—Acquisitions and Valuations since February 2006. Prior to that time, he served as Vice President - Acquisitions and Valuations of HCP since November 1998. He joined HCP after 20 years with Valuation Counselors, Inc., a national healthcare valuation firm. |
Thomas Klaritch |
Mr. Thomas M. Klaritch is Executive Vice President - Medical Office Properties of HCP Inc. From October 2003 through April 2008, he served as the company Senior Vice President—Medical Office Properties. Prior to that, he was a founding member and Chief Financial Officer of MedCap Properties LLC, a real estate company located in Nashville, Tennessee that owned, operated and developed real estate in the healthcare field. HCP acquired MedCap Properties LLC in October 2003. Mr. Klaritch is a certified public accountant. |
Susan Tate |
Ms. Susan M. Tate is Executive Vice President - Post Acute and Hospitals of HCP Inc. From January 2009 through February 2012, she served as the company Executive Vice President—Asset Management and Senior Housing, and from February 2007 through January 2009 she served as the company Senior Vice President—Asset Management. Prior to joining the company, Ms. Tate spent 19 years at JPMorgan and its predecessor institutions in both healthcare and real estate lending positions, including as Vice President, Real Estate Corporate Banking. |
Kendall Young |
Mr. Kendall K. Young is Executive Vice President - Senior Housing of HCP Inc., since February 2012. From September 2010 through February 2012, he served as Executive Vice President. Prior to joining the Company, from May 2007 to September 2010, he was a Managing Director at Strategic Value Partners in Greenwich, Connecticut. In his position as Global Head of Asset Management, Mr. Young was responsible for managing all aspects of a commercial property portfolio. Before that, he held Managing Director positions with Merrill Lynch and GE Capital Real Estate, where he originated transactions and managed U.S. and international portfolios of real estate equity and debt investments. |
Michael McKee |
Mr. Michael D. McKee is Lead Independent Director of HCP Inc., since 1989. He has been Chief Executive Officer of Bentall Kennedy U.S., L.P. ("Bentall Kennedy"), one of the privately-owned real estate investment advisory firms in North America, since February 2010. Mr. McKee retired in September 2008 as the Chief Executive Officer and Vice Chairman of the Board of Directors of The Irvine Company, a privately-held real estate development and investment company, where he had been an executive officer since 1994. Prior to that, he was a partner with the law firm of Latham & Watkins LLP from 1986 to 1994. Mr. McKee is the Chairman of the Board of Directors of Realty Income Corporation (NYSE:O), a REIT, and serves on the Board of Directors of First American Financial Corporation (NYSE:FAF), a title insurance and financial services company, and of the Tiger Woods Foundation. He also previously served as a director of Mandalay Resort Group, Irvine Apartment Communities Inc. and Oasis Residential, Inc. |
Christine Garvey |
Ms. Christine N. Garvey is Independent Director of HCP, Inc. She was the Global Head of Corporate Real Estate Services at Deutsche Bank AG from 2001 to 2004. Prior to that, she served as Vice President, Worldwide Real Estate and Workplace Resources at Cisco Systems, Inc. and as Group Executive Vice President at Bank of America. Ms. Garvey has served as a member of the Board of Directors of ProLogis, Inc. (NYSE:PLD), a real estate investment trust ("REIT"), since June 2011, and was a member of the Board of Trustees and the Board of Directors, respectively, of its predecessors, ProLogis (since September 2005) and Catellus Development Corporation (since 1995). She is also a member of the Board of Directors of UnionBanCal Corporation, MPG Office Trust (NYSE:MPG), an office building REIT, and Toll Brothers, Inc. (NYSE:TOL) and served on the Board of Directors of Hilton Hotels Corporation through October 2007. |
David Henry |
Mr. David B. Henry is Independent Director of HCP Inc., since 2004. He has been Chief Executive Officer of Kimco Realty Corporation (NYSE:KIM), a REIT ("Kimco"), since December 2009 and President of Kimco since November 2008. Mr. Henry joined Kimco in 2001 as Vice Chairman and Chief Investment Officer after 23 years at GE, where he was Chief Investment Officer and Senior Vice President of GE Capital Real Estate and Chairman of GE Capital Investment Advisors. At GE, he was responsible for helping to manage real estate investments totaling more than $20 billion in 11 countries worldwide. Mr. Henry is a director of Fairfield County Bank, a $1.6 billion community bank in Ridgefield, Connecticut. He also serves as a Trustee and is a past Chairman of the International Council of Shopping Centers (ICSC), and is a member of the Real Estate Roundtable. |
Lauralee Martin |
Ms. Lauralee E. Martin is Independent Director of HCP Inc. She has been the Chief Executive Officer, Americas of Jones Lang LaSalle Incorporated (NYSE:JLL), one of the world's real estate services and money management firms, since January 2013. She has been the Executive Vice President and Chief Financial Officer of Jones Lang LaSalle since January 2002. In January 2005 she was appointed to the additional position of Chief Operating Officer. She has also served on its Board of Directors since 2005. Ms. Martin joined Jones Lang LaSalle after 15 years with Heller Financial, Inc. where she was Executive Vice President, Chief Financial Officer and President of the Real Estate Finance Division. Ms. Martin serves on the Board of Kaiser Aluminum Corporation (NYSE:KALU), a producer of aluminum products, and previously served as a director of KeyCorp (NYSE:KEY), one of the nation's bank based financial services companies, from 2003 through 2010 and of Gables Residential Trust, a real estate investment trust, from 1994 through 2005. |
Peter Rhein |
Mr. Peter L. Rhein is Independent Directorn of HCP Inc., since 1985. He has been a general partner of Sarlot and Rhein, a real estate investment partnership, since 1967 and member of the Management Committee of BBC Properties, LLC, a real estate investment and development company, since October 2001. From 1970 until 1984, he was employed in various capacities by Wells Fargo Realty Advisors and its affiliates. From 1985 to 2008, Mr. Rhein chaired the Audit Committee of HCP. From 1993 to 1998, Mr. Rhein was a director and chaired the Audit Committee of Oasis Residential, Inc., a NYSE REIT. Since 2004, Mr. Rhein has served as a director of Cohen & Steers, Inc. (NYSE:CNS), one of the nation's managers of real estate mutual funds. He also serves as a member of the Board of Visitors, Claremont Graduate University, School of Politics and Economics. He is a certified public accountant. |
Joseph Sullivan |
Mr. Joseph P. Sullivan is Independent Director of HCP Inc., since 2004. He is Chairman Emeritus of the Board of Advisors of RAND Health and past Chairman of the Board of Advisors of the UCLA Medical Center. From March 2000 through March 2003, he served as Chairman of the Board and Chief Executive Officer of Protocare, Inc., a healthcare clinical trials and consulting organization. Mr. Sullivan was Chairman of the Board, Chief Executive Officer and President of American Health Properties, Inc. from 1993 until HCP's acquisition of American Health Properties in 1999. He is a director of MPG Office Trust, Inc. (NYSE:MPG), an office building REIT, and CIGNA Corporation (NYSE:CI), a global health service company. Mr. Sullivan served as a director of Covenant Care, Inc., a provider of long term care services, from 2000 until 2006, and of Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN), a biopharmaceutical company, from 2003 until 2012. He also has 20 years of investment banking experience with Goldman Sachs. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
James Flaherty |
11,798,700 |
Kenneth Roath |
-- |
Timothy Schoen |
2,559,960 |
Paul Gallagher |
4,285,040 |
James Mercer |
2,334,950 |
Jonathan Bergschneider |
-- |
Edward Henning |
1,465,780 |
Thomas Kirby |
-- |
Thomas Klaritch |
1,410,030 |
Susan Tate |
1,511,340 |
Kendall Young |
-- |
Michael McKee |
-- |
Christine Garvey |
-- |
David Henry |
-- |
Lauralee Martin |
-- |
Peter Rhein |
-- |
Joseph Sullivan |
-- |
As Of 30 Dec 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
James Flaherty |
4,108,575 | 39,860,920 |
Kenneth Roath |
0 | 0 |
Timothy Schoen |
44,864 | 466,338 |
Paul Gallagher |
252,865 | 1,546,839 |
James Mercer |
0 | 0 |
Jonathan Bergschneider |
0 | 0 |
Edward Henning |
701,980 | 8,040,200 |
Thomas Kirby |
0 | 0 |
Thomas Klaritch |
52,400 | 1,080,340 |
Susan Tate |
10,056 | 143,700 |
Kendall Young |
0 | 0 |
Michael McKee |
0 | 0 |
Christine Garvey |
0 | 0 |
David Henry |
0 | 0 |
Lauralee Martin |
0 | 0 |
Peter Rhein |
0 | 0 |
Joseph Sullivan |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
FLAHERTY JAMES F III |
13,144 | $47.89 |
SCHOEN TIMOTHY M |
1,262 | $47.89 |
TATE SUSAN M |
505 | $47.89 |
BERGSCHNEIDER JONATHAN M |
631 | $47.89 |
GALLAGHER PAUL F |
4,382 | $47.89 |
ANDERSON SCOTT A |
1,602 | $54.07 |
ANDERSON SCOTT A |
1,602 | $41.64 |
ANDERSON SCOTT A |
2,224 | $54.06 |
KIRBY THOMAS D |
4,500 | $53.58 |
HENNING EDWARD J |
4,579 | $23.34 |
KIRBY THOMAS D |
3,888 | $28.35 |
HENNING EDWARD J |
3,350 | $36.96 |
KIRBY THOMAS D |
2,806 | $36.96 |
HENNING EDWARD J |
23,105 | $53.50 |
HENNING EDWARD J |
10,444 | $28.35 |
HENNING EDWARD J |
4,732 | $41.64 |
KIRBY THOMAS D |
6,694 | $53.55 |
HENNING EDWARD J |
9,003 | $53.47 |
KLARITCH THOMAS M |
14,540 | $53.51 |
KLARITCH THOMAS M |
14,540 | $27.52 |
MCKEE MICHAEL DALE |
3,000 | $0.00 |
ROATH KENNETH B |
3,000 | $0.00 |
GARVEY CHRISTINE N |
3,000 | $0.00 |
RHEIN PETER L |
3,000 | $0.00 |
SULLIVAN JOSEPH P |
3,000 | $0.00 |

